Novo Nordisk.

Ozempic, Wegovy, Mounjaro and Zepbound are peptides: short chains of amino acids that copy the gut hormone GLP-1, which tells your brain you are full and slows your stomach. Novo Nordisk and Eli Lilly built them for type 2 diabetes. Users lose 15 to 20% of body weight, which makes them the biggest weight-loss drugs in history.

The future of longevity is more healthy years, not just more years. I predict biotech, AI, diagnostics, and personalized medicine extend healthy human lifespan significantly, and the focus shifts from treating disease to preventing, delaying, and potentially reversing aging itself. People over 60 spend $19 trillion today, $40 trillion by 2036 on my call. Follow the money: Jeff Bezos backs Altos Labs, Sam Altman backs Retro Biosciences, Bryan Johnson spends $2 million a year on his own body, and Novo Nordisk and Eli Lilly now sell their weight-loss drugs as the first longevity pills. Watch who sells you the subscription: big pharma never found a cure in its life, because cures kill subscriptions. I frame longevity as several exponential technologies hitting medicine at once. The question is no longer if, but how soon, and for whom. My warning stays: no pill beats real food and a body you actually use.